Studies have shown that PRR13 plays an important role in chemotherapeutic resistance by reducing the expression of the pro-apoptotic gene thrombospondin-1 (TSP1), thereby inhibiting taxol-induced apoptosis in cancer cells (Verleih et al., 2010). Here, THBS1 is linked to cancer.